| DNA damage response and resistance of cancer stem cells E Abad, D Graifer, A Lyakhovich Cancer Letters 474, 106-117, 2020 | 118 | 2020 |
| Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer*[S] E Abad, Y García-Mayea, C Mir, D Sebastian, A Zorzano, D Potesil, ... Molecular & Cellular Proteomics 18 (2), 231-244, 2019 | 41 | 2019 |
| Movement of mitochondria with mutant DNA through extracellular vesicles helps cancer cells acquire chemoresistance E Abad, A Lyakhovich ChemMedChem 17 (4), e202100642, 2022 | 37 | 2022 |
| Reactive oxygen species-mediated autophagy defines the fate of cancer stem cells ME Lleonart, E Abad, D Graifer, A Lyakhovich Antioxidants & Redox Signaling 28 (11), 1066-1079, 2018 | 27 | 2018 |
| Triphenilphosphonium analogs of chloramphenicol as dual-acting antimicrobial and antiproliferating agents JA Pavlova, ZZ Khairullina, AG Tereshchenkov, PA Nazarov, DA Lukianov, ... Antibiotics 10 (5), 489, 2021 | 24 | 2021 |
| Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem‐like cells contributes to chemoresistance E Abad, L Civit, D Potesil, Z Zdrahal, A Lyakhovich The FEBS journal 288 (7), 2184-2202, 2021 | 16 | 2021 |
| Activation of glycogenolysis and glycolysis in breast cancer stem cell models E Abad, S Samino, O Yanes, D Potesil, Z Zdrahal, A Lyakhovich Biochimica et Biophysica Acta (BBA)/Molecular Basis of Disease 1866 (10 …, 2020 | 13 | 2020 |
| Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis SA Best, CJ Vandenberg, E Abad, L Whitehead, L Guiu, S Ding, ... Cell Death & Disease 11 (10), 877, 2020 | 11 | 2020 |
| Identification of metabolic changes leading to cancer susceptibility in Fanconi anemia cells E Abad, S Samino, RL Grodzicki, G Pagano, M Trifuoggi, D Graifer, ... Cancer Letters 503, 185-196, 2021 | 9 | 2021 |
| Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control? A Janic, E Abad, I Amelio Cell Death & Differentiation, 1-8, 2024 | 6 | 2024 |
| The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability E Abad, J Sandoz, G Romero, I Zadra, J Urgel-Solas, P Borredat, ... Journal of Experimental & Clinical Cancer Research 43 (1), 127, 2024 | 4 | 2024 |
| Antibiotics as repurposed drugs for anticancer therapy E Abad, Y Garcia-Mayea, C Mir, D Sebastian, A Zorzano, D Potesil, ... FEBS OPEN BIO 8, 313-313, 2018 | | 2018 |
| Targeting cancer chemoresistance via mitochondrial dysfunction and autophagy inhibition A LyakhovichI, E AbadI, Y Garcia-MayeaI, C MirI, Y SunI, M LleonartI FEBS JOURNAL 284, 275-275, 2017 | | 2017 |
